Eledon T1D Trial: Immunomodulation with a CD40L antibody in combo with Transplanted Islet Cells

Long Non-coding RNAs (lncRNA) as a Novel Source of Beta Cell Autoantigens in Type 1 Diabetes

Can Islets Evade the Immune System Safely: Designing Tolerance without Compromising Host Defense

Linking Biological Rhythms to Beta Cell Maturation - Juan Alvarez, PhD, UPenn

Glucagon Secretion by Panc Alpha-cells Requires an Intact Tubulin-Cytoskeleton-Primary Cilium Axis

Saliva-based at-home GRS Testing for Scalable & Accessible T1D Screening - Yuta Matsuda, T1D Scout

Human Pancreas Integrated histopath through T1D progression - Verena van der Heide & Sara McArdle

the(sugar)science presents: the Diabdocs 2025 Cohort

High-throughput perturbation screens to decode human immune states-a sc cytokine dictionary of blood

Longitudinal monitoring of Type 1 Diabetes progression to disease onset - Lonnie Shea, PhD

Type 1 Diabetes Monitoring Panel - Challenges for Implementation and Engagement

Type 1 Diabetes Screening Panel: Moving from Research to Clinical Implementation

Panel: What would the earliest detection of Type 1 Diabetes look like?

Goal-oriented in Silicon Perturbations: Novel Counterfactual Deep Learning Framework in T1D

How the Human Immunome Project/IHM may inform Type 1 Diabetes - John Tsang, PhD, Yale

WAVE T1D Clinical Trial: Multicenter RCT Combo therapy in New-Onset Type 1 Diabetes

Multiscale Microenvironment Control in Stem Cell-Derived Pancreatic Progenitor Production

IL-17 Deficiency Protects NOD Mice from Diabetes through Altering Intestinal Antigen Presentation

Islet Cellularity in Health & Type 1 Diabetes: insights from deep tissue 3D imaging-Ulf Ahlgren, PhD

2025 Most Watched Highlights: Fast Tracking Stem Cell Derived Islets to the Clinic - What is Needed?

2025 Most Watched Highlights: Peter Thompson, PhD, & Jasmine Pipella, PhD Candidate

2025 Most Watched Highlights: Xin Chen, PhD

2025 Most Watched Highlights:Thomas Hill, PhD

2025 Most Watched Highlights: Ulf Hannelius, CEO

2025 Most Watched Highlights: Luc Teyton, MD PhD

2025 Most Watched Highlights: Sonja Schrepfer, MD PhD, & Curtis Cetrulo, MD

2025 Most Watched Highlights: Rene van Tienhoven, PhD

2025 Most Watched Highlight: Eric Chang, PhD

2025 Most Watched Highlights: Sana Biotech Update

State of the Science: Fast Tracking Stem cell derived islets to the clinic-what is needed?

Small Things Matter: Lack of Extra Islet Beta Cells in T1D - Katy Murall, PhD, University of Exeter

T1D Th1nk Tank: Christof Westenfelder, MD CEO, SymbioCellTech

Code to Cure: Build Models, Agents, AI-XR, co-scientists to Drive Biomedical Innovation

The Search for Diabetes-Specific T-cell Repertoires - Michel Edwar Mickael, PhD

Serum Metabolic Profiling Reveals Gut Microbiota-linked Differences in T1D in Discordant Twins

Improving Prediction of Type 1 Diabetes Across Studies - Erin Templeman, PhD Candidate Oram Lab

Transcriptomics of Autoimmune Disease Identifies FGFR1 as a Target for Panc Beta-Cell Protection

Molecular Mechanisms of Human Pancreatic Islet Dysfunction Under Overnutrition Metabolic Stress

Transcriptomic & Functional Divergence of Stem Cell-derived & Primary Islets Under Acute Hypoxia

1c Metabolisms in CD8 T cell Responses during Type 1 Diabetes - Gabriela Ramirez-Hernandez, PhD

Endogenous Retroviruses & Type 1 Diabetes Conserved & Mutated Epitopes of the Virus-like Gag Antigen

Immune & Apoptosis-Related Gene Signatures in Alpha & Beta Cells Contribute to their Fate in T1D

Hematopoietic Stem Cell Transplantation Promotes Islet Transplant Tolerance & Diabetes Reversal

D Challenge 2025 Bootcamp: PANC-DB and PanKbase

Does Type 1 Diabetes Start in the Exocrine Pancreas? - Kathrin Maedler, PhD, University of Bremen

How to Understand the Initiation of Type 1 Diabetes - Luc Teyton, MD PhD, Scripps

Clip from Dr. Theodore dos Santos' talk

Integrative sc Multi-omics Profiling of Pancreatic Islets Identifies TID Genes & Regulatory Signals

Vitamin D & Type 1 Diabetes - Benjamin Nwosu, MD, Cohen Children's Medical Center

Old Dogs, New Tricks: T Cells Drive Beta Cell Senescence in Type 1 Diabetes - Jasmine Pipella

Wireless Oxygen-generating Device for Long-term Cell Therapy in Type 1 Diabetes - Matt Bochenek, PhD

Endogenous Targeting Lipid Nanoparticles (ENDO) Platform for Systemic Delivery of mRNA to Pancreas

Type 1 Diabetes Clinical Trial to Protect & Regenerate Beta Cells, Fouad Kandeel, MD PhD

Augmented Immune Modulation with Beta Cell Protection-Verapamil Sustains Remission with Low-dose ATG

Hypoimmune Cells in Xenotransplantation - Sonja Schrepfer, MD PhD & Curtis Cetrulo, MD, Cedars Sinai

Type 1 Diabetes Clinical Trial: Denosumab for Type 1 Diabetes, Rupi Vasavada, PhD

Epigenetic Regulation of Type 1 Diabetes Implications for Disease Management

T1D Th1nk Tank: Kagan Karakus, MD, University of Colorado

T1D Th1nk Tank: Nikki Farnsworth, PhD, Colorado School of Mines

T1D Th1nk Tank: Karoliina Hirvonen, PhD, University of Turku